$1.59
-0.10 (-5.92%)
Open$1.69
Previous Close$1.69
Day High$1.72
Day Low$1.54
52W High$3.39
52W Low$0.16
Volume—
Avg Volume24.02M
Market Cap278.66M
P/E Ratio—
EPS$-1.26
SectorBiotechnology
Analyst Ratings
Strong Buy
9 analysts
Price Target
+2,087.4% upside
Current
$1.59
$1.59
Target
$34.78
$34.78
$27.07
$34.78 avg
$51.13
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 6.62M | 8.58M | 5.83M |
| Net Income | -292,346,966 | -341,393,887 | -1,267,217 |
| Profit Margin | -4,416.2% | -4,195.4% | -21.7% |
| EBITDA | -313,515,233 | -386,453,187 | -1,820,131 |
| Free Cash Flow | — | — | -1,133,887 |
| Rev Growth | -22.9% | -22.9% | +8.5% |
| Debt/Equity | 1.25 | 1.25 | 0.66 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |